Literature DB >> 1933777

Intratumoral heterogeneity in DNA ploidy of esophageal squamous cell carcinomas.

K Sasaki1, T Murakami, T Murakami, M Nakamura.   

Abstract

Intratumoral heterogeneity in DNA ploidy was investigated in 23 cases of squamous cell carcinoma of the esophagus. Nuclear DNA content was determined for multiple samples taken from the same tumor, using a flow cytometric technique. The incidence of DNA aneuploidy was 87% in this series, and DNA indices ranged from 0.78 to 2.64 but most of them fell within values between 1 and 2. Of these cases ten (43.5%) showed intratumoral heterogeneity in DNA ploidy; in addition to a diploid population, one to four heterogeneous aneuploid subpopulations were discernible in the same tumor. However, morphologic variation was minimal within the same tumor. DNA index seen in metastatic lesions was identical with one of those in the primary lesion. Mechanisms responsible for intratumoral difference in DNA ploidy are also discussed from the aspect of tumor progression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933777     DOI: 10.1002/1097-0142(19911201)68:11<2403::aid-cncr2820681112>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Use of flow cytometry in the analysis of stage III squamous cell carcinoma of the oesophagus and its association with MIB-1.

Authors:  K Y Lam; L Ma; S Y Law; L K Cheung; T F Luk; J Wong
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Chromosomal aneuploidies and combinational fluorescence in situ hybridization probe panels are useful for predicting prognosis for esophageal squamous cell carcinoma.

Authors:  Jia-Jie Hao; Han-Qing Yao; Guang-Yun Dai; Wei Kang; Xue-Mei Jia; Xin Xu; Yan Cai; Qi-Min Zhan; Gui-Qi Wang; Ming-Rong Wang
Journal:  J Gastroenterol       Date:  2014-05-11       Impact factor: 7.527

3.  Influence of preoperative radiotherapy on DNA ploidy in squamous cell carcinomas of the oesophagus.

Authors:  R Porschen; G Bevers; U Remy; S Schauseil; F Borchard
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

4.  Esophageal squamous cell carcinoma: pathology and prognosis.

Authors:  H Ide; T Nakamura; K Hayashi; T Endo; A Kobayashi; R Eguchi; F Hanyu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

5.  Heterogeneity of DNA content in multiple synchronous hepatocellular carcinomas.

Authors:  A M Hui; S Kawasaki; H Imamura; S Miyagawa; K Ishii; T Katsuyama; M Makuuchi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.

Authors:  Chiara Mignogna; Stefania Staibano; Vincenzo Altieri; Gaetano De Rosa; Giuseppe Pannone; Angela Santoro; Rosanna Zamparese; Massimino D'Armiento; Romualdo Rocchetti; Ernesto Mezza; Mario Nasti; Viviana Strazzullo; Vittorino Montanaro; Massimo Mascolo; Pantaleo Bufo
Journal:  BMC Cancer       Date:  2006-12-19       Impact factor: 4.430

7.  Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.

Authors:  B Ljungberg; C Mehle; R Stenling; G Roos
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

8.  Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.

Authors:  Y Kakeji; D Korenaga; S Tsujitani; H Baba; H Anai; Y Maehara; K Sugimachi
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.